Christopher Dinsmore, Chief Scientific Officer at Kronos Bio, Inc. (KRON), sold 7,366 shares at $1.18 ($9K) on 2024-01-04, disclosed to the SEC on 2024-01-05.
Open-market sale of $9k KRON by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KRON | SELL | 2023-02-24 | $11K | — | Filing → |
| KRON | SELL | 2022-12-14 | $17K | — | Filing → |
| KRON | SELL | 2021-12-15 | $279K | — | Filing → |